Publication | Open Access
LBA16 IMpassion130: Final OS analysis from the pivotal phase III study of atezolizumab + nab-paclitaxel vs placebo + nab-paclitaxel in previously untreated locally advanced or metastatic triple-negative breast cancer
61
Citations
0
References
2020
Year
Breast OncologyFinal Os AnalysisMedicinePharmacologyPathologyLba16 Impassion130Breast CancerCancer TreatmentOncologyRadiation OncologyMolecular Oncology
No additional data available for this publication yet. Check back later!